Stay updated on Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Wording updated to clarify that PubMed publications are auto-filled and may not be about the study, and the page revision is now v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:44:47.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Removal of the funding lapse banner regarding government funding and NIH Clinical Center operations; core trial information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:28:48.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected on the page; the content remains focused on study details and eligibility criteria.
    Difference
    0.4%
    Check dated 2025-10-27T20:53:46.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Summary of changes: updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T07:59:29.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Upgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T04:41:00.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    Updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-14T22:08:22.000Z thumbnail image

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page.